Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb;56(2):739-42.
doi: 10.1128/AAC.05794-11. Epub 2011 Dec 5.

High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York hospital

Ephraim E Back  1 , Elisa J O'Grady, Joshua D Back
Affiliations

High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York hospital

Ephraim E Back et al. Antimicrob Agents Chemother. 2012 Feb.

Abstract

The objective of this study was to evaluate the rates of clindamycin and erythromycin resistance among group B Streptococcus (GBS)-positive isolates cultured from pregnant women in an upstate New York community hospital. All GBS-positive perinatal rectovaginal cultures obtained from January 2010 through October 2011 were tested for resistance to erythromycin and clindamycin. Among the 688 GBS-positive cultures, clindamycin resistance was found in 38.4% and erythromycin resistance was found in 50.7%. Rates of GBS resistance to clindamycin and erythromycin are much higher than reported in earlier U.S. studies, suggesting both increasing resistance and regional variation in resistance. These findings lend strong support to the CDC and American College of Obstetricians and Gynecologists (ACOG) recommendations that clindamycin use for intrapartum antibiotic prophylaxis be restricted to penicillin-allergic women at high risk of anaphylaxis and that GBS isolates be tested for antibiotic resistance prior to the use of clindamycin in these women.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Total numbers of rectovaginal cultures and GBS-positive cultures and percentages of GBS-positive isolates resistant to erythromycin or clindamycin.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. American College of Obstetricians and Gynecologists 2011. Committee opinion no. 485: prevention of early-onset group B streptococcal disease in newborns. Obstet. Gynecol. 117: 1019–1027 - PubMed
    1. Blaschke AJ, et al. 2010. Clindamycin-resistant group B streptococcus and failure of intrapartum prophylaxis to prevent early-onset disease. J. Pediatr. 156: 501–503 - PMC - PubMed
    1. Borchardt SM, et al. 2006. Frequency of antimicrobial resistance among invasive and colonizing group B streptococcal isolates. BMC Infect. Dis. 6: 57. - PMC - PubMed
    1. Castor ML, et al. 2008. Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect. Dis. Obstet. Gynecol. 2008: 727505. - PMC - PubMed
    1. Centers for Disease Control and Prevention 2002. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Morb. Mortal. Wkly. Rep. 51 (RR-11): 1–22 - PubMed

MeSH terms